Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Mucosa | 10 | 2018 | 51 | 1.560 |
Why?
|
| Smoking | 12 | 2018 | 473 | 1.370 |
Why?
|
| Herpesvirus 8, Human | 7 | 2010 | 12 | 1.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 6 | 2017 | 65 | 1.020 |
Why?
|
| Cell Differentiation | 7 | 2018 | 406 | 0.920 |
Why?
|
| Lung | 4 | 2018 | 378 | 0.720 |
Why?
|
| Viral Proteins | 3 | 2007 | 63 | 0.560 |
Why?
|
| Antigens, Viral | 3 | 2010 | 24 | 0.550 |
Why?
|
| Epithelium | 5 | 2017 | 39 | 0.530 |
Why?
|
| Lymphoma | 3 | 2006 | 25 | 0.500 |
Why?
|
| Trans-Activators | 4 | 2016 | 118 | 0.490 |
Why?
|
| Nuclear Proteins | 3 | 2010 | 247 | 0.470 |
Why?
|
| Stem Cells | 2 | 2016 | 121 | 0.460 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2018 | 204 | 0.440 |
Why?
|
| Gene Expression Profiling | 9 | 2018 | 452 | 0.430 |
Why?
|
| Epithelial Cells | 6 | 2018 | 247 | 0.420 |
Why?
|
| Cell Culture Techniques | 2 | 2013 | 116 | 0.390 |
Why?
|
| Immediate-Early Proteins | 3 | 2007 | 15 | 0.390 |
Why?
|
| Sarcoma, Kaposi | 3 | 2011 | 8 | 0.360 |
Why?
|
| Herpesviridae Infections | 3 | 2010 | 17 | 0.350 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2018 | 329 | 0.330 |
Why?
|
| Humans | 34 | 2018 | 27968 | 0.310 |
Why?
|
| Promoter Regions, Genetic | 3 | 2007 | 343 | 0.300 |
Why?
|
| Bronchi | 3 | 2018 | 38 | 0.290 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 403 | 0.290 |
Why?
|
| Melanoma | 1 | 2009 | 140 | 0.280 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2006 | 12 | 0.260 |
Why?
|
| Transcriptome | 2 | 2018 | 214 | 0.250 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 632 | 0.240 |
Why?
|
| Adult | 14 | 2018 | 7703 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 546 | 0.230 |
Why?
|
| Case-Control Studies | 6 | 2016 | 719 | 0.230 |
Why?
|
| Laminin | 1 | 2004 | 21 | 0.230 |
Why?
|
| Proteoglycans | 1 | 2004 | 38 | 0.230 |
Why?
|
| Drug Combinations | 1 | 2004 | 50 | 0.230 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2006 | 268 | 0.230 |
Why?
|
| DNA Methylation | 5 | 2018 | 151 | 0.220 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 147 | 0.220 |
Why?
|
| Respiratory Function Tests | 3 | 2018 | 27 | 0.210 |
Why?
|
| Collagen | 1 | 2004 | 156 | 0.210 |
Why?
|
| Male | 15 | 2018 | 13424 | 0.200 |
Why?
|
| Middle Aged | 10 | 2018 | 7111 | 0.190 |
Why?
|
| Genome, Human | 3 | 2017 | 69 | 0.180 |
Why?
|
| Healthy Volunteers | 2 | 2018 | 49 | 0.180 |
Why?
|
| Wnt Signaling Pathway | 2 | 2018 | 56 | 0.170 |
Why?
|
| Alleles | 2 | 2018 | 350 | 0.170 |
Why?
|
| Cluster Analysis | 4 | 2016 | 124 | 0.170 |
Why?
|
| Female | 13 | 2018 | 15074 | 0.170 |
Why?
|
| Cell-Derived Microparticles | 2 | 2016 | 11 | 0.160 |
Why?
|
| Phenotype | 5 | 2016 | 680 | 0.160 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2018 | 8 | 0.150 |
Why?
|
| Diabetic Foot | 1 | 2018 | 17 | 0.150 |
Why?
|
| Exome | 1 | 2018 | 30 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2016 | 1433 | 0.150 |
Why?
|
| Osteoclasts | 1 | 2018 | 29 | 0.150 |
Why?
|
| DNA Copy Number Variations | 2 | 2015 | 36 | 0.150 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 35 | 0.150 |
Why?
|
| beta Catenin | 1 | 2018 | 65 | 0.150 |
Why?
|
| Mutation | 2 | 2016 | 843 | 0.140 |
Why?
|
| Transcriptional Activation | 3 | 2007 | 86 | 0.140 |
Why?
|
| Monocytes | 1 | 2018 | 135 | 0.140 |
Why?
|
| Biomarkers | 3 | 2018 | 756 | 0.140 |
Why?
|
| Gene Expression | 2 | 2016 | 415 | 0.130 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2016 | 2 | 0.130 |
Why?
|
| Qatar | 4 | 2018 | 8 | 0.130 |
Why?
|
| Jagged-1 Protein | 1 | 2016 | 6 | 0.130 |
Why?
|
| Autophagy | 1 | 2017 | 73 | 0.130 |
Why?
|
| Receptors, Notch | 1 | 2016 | 45 | 0.130 |
Why?
|
| Immunity | 1 | 2016 | 26 | 0.130 |
Why?
|
| Respiration | 1 | 2016 | 45 | 0.130 |
Why?
|
| Rhadinovirus | 2 | 2007 | 3 | 0.120 |
Why?
|
| Gene Dosage | 1 | 2015 | 35 | 0.120 |
Why?
|
| Cigarette Smoking | 1 | 2017 | 82 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2018 | 884 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2017 | 984 | 0.120 |
Why?
|
| Genetics, Population | 1 | 2015 | 73 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2016 | 43 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 665 | 0.120 |
Why?
|
| Metabolome | 1 | 2015 | 68 | 0.120 |
Why?
|
| Proteins | 1 | 2017 | 251 | 0.120 |
Why?
|
| Metabolomics | 1 | 2015 | 85 | 0.120 |
Why?
|
| Genomics | 1 | 2015 | 122 | 0.120 |
Why?
|
| Endothelial Cells | 2 | 2016 | 350 | 0.110 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 117 | 0.110 |
Why?
|
| Smoke | 1 | 2014 | 37 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2014 | 8 | 0.110 |
Why?
|
| Multipotent Stem Cells | 1 | 2013 | 5 | 0.110 |
Why?
|
| Smoking Cessation | 2 | 2016 | 408 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2014 | 75 | 0.110 |
Why?
|
| Cilia | 1 | 2014 | 41 | 0.110 |
Why?
|
| Cellular Senescence | 1 | 2014 | 125 | 0.110 |
Why?
|
| Diabetic Retinopathy | 1 | 2015 | 109 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 327 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 194 | 0.100 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2011 | 2 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2010 | 103 | 0.090 |
Why?
|
| Up-Regulation | 3 | 2017 | 246 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2015 | 294 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 769 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2015 | 483 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2011 | 191 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2010 | 1314 | 0.090 |
Why?
|
| Lymphoma, Primary Effusion | 1 | 2010 | 1 | 0.080 |
Why?
|
| Virus Activation | 2 | 2007 | 9 | 0.080 |
Why?
|
| Cell Line | 2 | 2013 | 695 | 0.080 |
Why?
|
| Enzyme Activators | 1 | 2009 | 9 | 0.080 |
Why?
|
| Genome-Wide Association Study | 3 | 2015 | 234 | 0.080 |
Why?
|
| Diterpenes | 1 | 2009 | 19 | 0.080 |
Why?
|
| Protein Kinase C | 1 | 2009 | 73 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2009 | 86 | 0.080 |
Why?
|
| Interferon-beta | 1 | 2009 | 40 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2009 | 802 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 101 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2009 | 161 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 156 | 0.070 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2007 | 32 | 0.070 |
Why?
|
| Genes, Immediate-Early | 1 | 2007 | 5 | 0.070 |
Why?
|
| Autocrine Communication | 1 | 2006 | 7 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2007 | 109 | 0.070 |
Why?
|
| Interleukins | 1 | 2007 | 112 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 109 | 0.070 |
Why?
|
| Herpesvirus 4, Human | 1 | 2007 | 42 | 0.070 |
Why?
|
| Forced Expiratory Volume | 2 | 2016 | 17 | 0.060 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2006 | 6 | 0.060 |
Why?
|
| Sirolimus | 1 | 2006 | 76 | 0.060 |
Why?
|
| Computational Biology | 2 | 2018 | 155 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 461 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2017 | 199 | 0.060 |
Why?
|
| Cotinine | 2 | 2016 | 45 | 0.060 |
Why?
|
| Gene Frequency | 2 | 2016 | 185 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2005 | 9 | 0.060 |
Why?
|
| Nicotine | 2 | 2016 | 86 | 0.060 |
Why?
|
| Haplotypes | 2 | 2016 | 283 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2014 | 657 | 0.060 |
Why?
|
| Animals | 4 | 2007 | 10370 | 0.060 |
Why?
|
| Subrenal Capsule Assay | 1 | 2004 | 5 | 0.060 |
Why?
|
| Exudates and Transudates | 1 | 2004 | 11 | 0.060 |
Why?
|
| Ganciclovir | 1 | 2004 | 7 | 0.060 |
Why?
|
| Abdominal Wall | 1 | 2004 | 9 | 0.060 |
Why?
|
| Mice, SCID | 1 | 2004 | 60 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 60 | 0.060 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 89 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 154 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 473 | 0.050 |
Why?
|
| Virus Latency | 1 | 2003 | 9 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2004 | 112 | 0.050 |
Why?
|
| Virus Replication | 1 | 2003 | 65 | 0.050 |
Why?
|
| Chromatography, Liquid | 2 | 2015 | 76 | 0.050 |
Why?
|
| HIV Infections | 1 | 2005 | 157 | 0.050 |
Why?
|
| Risk Factors | 2 | 2018 | 2078 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 679 | 0.050 |
Why?
|
| Disease Progression | 2 | 2015 | 472 | 0.040 |
Why?
|
| Apoptosis | 2 | 2016 | 772 | 0.040 |
Why?
|
| CpG Islands | 1 | 2018 | 26 | 0.040 |
Why?
|
| Diabetic Neuropathies | 1 | 2018 | 14 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 51 | 0.040 |
Why?
|
| Epigenomics | 1 | 2018 | 28 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 241 | 0.040 |
Why?
|
| Reference Values | 1 | 2018 | 199 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 76 | 0.040 |
Why?
|
| Mice | 2 | 2006 | 4621 | 0.040 |
Why?
|
| Young Adult | 2 | 2016 | 2714 | 0.040 |
Why?
|
| Sequestosome-1 Protein | 1 | 2017 | 2 | 0.040 |
Why?
|
| Autophagosomes | 1 | 2017 | 5 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 33 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 49 | 0.030 |
Why?
|
| Lysosomes | 1 | 2017 | 56 | 0.030 |
Why?
|
| Carboxyhemoglobin | 1 | 2016 | 3 | 0.030 |
Why?
|
| Sputum | 1 | 2016 | 8 | 0.030 |
Why?
|
| Cough | 1 | 2016 | 11 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 26 | 0.030 |
Why?
|
| Thorax | 1 | 2016 | 29 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 33 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 77 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 112 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 2016 | 47 | 0.030 |
Why?
|
| Capillaries | 1 | 2016 | 32 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 109 | 0.030 |
Why?
|
| Genome | 1 | 2016 | 56 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 58 | 0.030 |
Why?
|
| RNA Interference | 1 | 2016 | 137 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 20 | 0.030 |
Why?
|
| DNA | 1 | 2017 | 371 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 456 | 0.030 |
Why?
|
| Telomere Shortening | 1 | 2014 | 4 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2015 | 34 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 93 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 112 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 510 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 190 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 210 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 562 | 0.030 |
Why?
|
| Telomere | 1 | 2014 | 34 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2014 | 3 | 0.030 |
Why?
|
| Retroviridae | 1 | 2013 | 16 | 0.030 |
Why?
|
| Telomerase | 1 | 2013 | 37 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 1011 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 9 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 325 | 0.030 |
Why?
|
| Transfection | 1 | 2013 | 317 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2017 | 667 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 967 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 133 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 57 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 404 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 657 | 0.020 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2007 | 27 | 0.020 |
Why?
|
| Transgenes | 1 | 2007 | 63 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2007 | 80 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 188 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 5383 | 0.020 |
Why?
|
| Cell Movement | 1 | 2007 | 365 | 0.020 |
Why?
|
| Cytokines | 1 | 2006 | 446 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2004 | 111 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 687 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1048 | 0.010 |
Why?
|